American Healthcare REIT (NYSE:AHR) Announces Quarterly Earnings Results

American Healthcare REIT (NYSE:AHR) posted its quarterly earnings data on Thursday. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.02, Zacks reports. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.The business had revenue of $572.94 million for the quarter, compared to analysts’ expectations of $552.76 million. During the same quarter in the previous year, the firm earned $0.36 earnings per share. The business’s revenue was up 9.4% on a year-over-year basis. American Healthcare REIT updated its FY 2025 guidance to 1.690-1.72 EPS.

American Healthcare REIT Trading Up 1.7%

AHR traded up $0.78 on Thursday, hitting $47.87. 2,406,401 shares of the company were exchanged, compared to its average volume of 1,368,584. The firm has a fifty day simple moving average of $42.83 and a two-hundred day simple moving average of $38.64. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.48 and a current ratio of 0.48. American Healthcare REIT has a 12 month low of $25.25 and a 12 month high of $48.21. The stock has a market capitalization of $8.07 billion, a PE ratio of -217.61, a price-to-earnings-growth ratio of 2.35 and a beta of 0.98.

American Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 17th. Investors of record on Tuesday, September 30th were given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 2.1%. The ex-dividend date was Tuesday, September 30th. American Healthcare REIT’s dividend payout ratio (DPR) is presently -454.55%.

Insider Transactions at American Healthcare REIT

In related news, EVP Mark E. Foster sold 3,850 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total transaction of $161,276.50. Following the transaction, the executive vice president directly owned 59,100 shares in the company, valued at $2,475,699. This trade represents a 6.12% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.92% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. State of Wyoming bought a new stake in American Healthcare REIT in the second quarter worth $61,000. Geneos Wealth Management Inc. boosted its holdings in American Healthcare REIT by 35.2% in the second quarter. Geneos Wealth Management Inc. now owns 31,583 shares of the company’s stock worth $1,160,000 after acquiring an additional 8,218 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its holdings in American Healthcare REIT by 13.8% in the second quarter. CANADA LIFE ASSURANCE Co now owns 249,935 shares of the company’s stock worth $9,188,000 after acquiring an additional 30,224 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in American Healthcare REIT by 454.4% in the second quarter. Tower Research Capital LLC TRC now owns 22,989 shares of the company’s stock worth $845,000 after acquiring an additional 18,842 shares in the last quarter. Finally, Corient Private Wealth LLC boosted its holdings in American Healthcare REIT by 10.9% in the second quarter. Corient Private Wealth LLC now owns 8,909 shares of the company’s stock worth $327,000 after acquiring an additional 876 shares in the last quarter. Hedge funds and other institutional investors own 16.68% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on AHR shares. Weiss Ratings reiterated a “hold (c)” rating on shares of American Healthcare REIT in a research note on Wednesday, October 8th. Robert W. Baird initiated coverage on American Healthcare REIT in a research note on Friday, July 18th. They issued an “outperform” rating and a $41.00 target price on the stock. Truist Financial upped their target price on American Healthcare REIT from $44.00 to $46.00 and gave the stock a “buy” rating in a research note on Tuesday, August 26th. Scotiabank restated an “outperform” rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. Finally, UBS Group started coverage on American Healthcare REIT in a research note on Friday, September 19th. They issued a “buy” rating and a $51.00 target price on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $45.00.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.